Atossa Therapeutics (DE:YAG2)
FRANKFURT:YAG2
Holding DE:YAG2?
Track your performance easily

Atossa Therapeutics (YAG2) Financial Statements

1 Followers

Atossa Therapeutics Financial Overview

Atossa Therapeutics's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; Atossa Therapeutics is scheduled to report earnings on August 14, 2024, and the estimated EPS forecast is €-0.06. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Dec 23Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -5.88M$ -7.75M$ -6.23M$ -9.83M$ -6.28M
EBITDA$ -5.87M$ -7.74M$ -6.23M$ -9.83M$ -6.28M
Net Income Common Stockholders$ -5.90M$ -7.76M$ -6.23M$ -9.83M$ 7.92M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 83.96M$ 88.46M$ 94.03M$ 99.50M$ 103.98M
Total Assets$ 91.09M$ 96.25M$ 101.69M$ 108.36M$ 115.46M
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -83.96M$ -88.46M$ -94.03M$ -99.50M$ -103.98M
Total Liabilities$ 5.33M$ 5.24M$ 3.44M$ 3.48M$ 2.94M
Stockholders Equity$ 85.76M$ 91.02M$ 98.25M$ 104.88M$ 113.26M
Cash Flow-
Free Cash Flow$ -4.70M$ -5.57M$ -3.88M$ -4.48M$ 111.11M
Operating Cash Flow$ -4.70M$ -5.57M$ -3.88M$ -4.46M$ 111.11M
Investing Cash Flow$ -6.00K-$ -1.00K$ -13.00K-
Financing Cash Flow$ 204.00K-$ -1.48M--
Currency in USD

Atossa Therapeutics Earnings and Revenue History

Atossa Therapeutics Debt to Assets

Atossa Therapeutics Cash Flow

Atossa Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis